Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 and the previous v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-12T15:15:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices including the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T20:33:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and system status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:50:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A glossary toggle has been added to the page to improve terms accessibility. Metadata headers were updated to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision version is now v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:34:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows a revision stamp 'v3.3.4', replacing the previous 'v3.3.3'. This is a minor technical update and does not affect the study details.
    Difference
    0.0%
    Check dated 2026-01-14T02:51:30.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section now shows regional grouping under the Locations heading, adding regions such as Beijing Municipality, Guangdong, Hebei, Hunan, Jiangsu, Jilin, Liaoning, Shandong, Shanghai Municipality, Shanxi, and Sichuan. Corresponding city-level location entries (Beijing Municipality Locations, Guangdong Locations, etc.) were removed.
    Difference
    1%
    Check dated 2025-12-23T13:38:59.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.